MODUVAL

Welcome to the Brand page for “MODUVAL”, which is offered here for In the statement, line 6, after diseases and line 9, after fields not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system should be inserted.;pharmaceutical products intended for the prevention or treatment of autoimmune and inflammatory diseases * not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system; * pharmaceutical products for the prevention or the treatment of inflammatory diseases in the ophthalmic, rheumatic, venous, dermatologic and cardio-metabolic fields * not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system *;.

Its status is currently believed to be active. Its class is unavailable. “MODUVAL” is believed to be currently owned by “BIOFARMA”.


Owner:
BIOFARMA
Owner Details
Description:
In the statement, line 6, after DISEASES and line 9, after FIELDS NOT INCLUDING PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF NEUROLOGICAL OR PSYCHIATRIC DISORDERS AND NOT INCLUDING PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM should be inserted.;Pharmaceutical products intended for the prevention or treatment of autoimmune and inflammatory diseases * not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system; * pharmaceutical products for the prevention or the treatment of inflammatory diseases in the ophthalmic, rheumatic, venous, dermatologic and cardio-metabolic fields * not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system *;
Categories: STATEMENT